0,903  0,003  Caspase 9 stimulant
0,896  0,003  CYP1A2 inhibitor
0,886  0,002  Antimutagenic
0,844  0,006  Antineoplastic (breast cancer)
0,845  0,011  Apoptosis agonist
0,815  0,005  Antileukemic
0,805  0,008  Antineoplastic (lung cancer)
0,783  0,004  AR expression inhibitor
0,776  0,005  Prostate cancer treatment
0,770  0,004  Caspase 3 stimulant
0,766  0,003  Breast cancer-resistant protein inhibitor
0,764  0,004  NOS2 expression inhibitor
0,764  0,004  Tubulin antagonist
0,754  0,004  Free radical scavenger
0,754  0,005  Antineoplastic (cervical cancer)
0,752  0,005  Aldehyde oxidase inhibitor
0,749  0,010  Antineoplastic (colorectal cancer)
0,743  0,010  Antineoplastic (colon cancer)
0,706  0,006  CTGF expression inhibitor
0,705  0,005  Antioxidant
0,684  0,005  Histamine release inhibitor
0,680  0,008  UGT1A9 substrate
0,671  0,008  Antineoplastic (melanoma)
0,674  0,011  Chemoprotective
0,662  0,004  P-glycoprotein inhibitor
0,658  0,007  Antineoplastic (non-small cell lung cancer)
0,642  0,006  Amyloid beta aggregation inhibitor
0,635  0,007  5 Hydroxytryptamine release inhibitor
0,628  0,006  Vasodilator, coronary
0,629  0,008  Cardioprotectant
0,625  0,011  12-Lipoxygenase inhibitor
0,619  0,007  Antiprotozoal (Leishmania)
0,604  0,007  Superoxide dismutase inhibitor
0,604  0,008  Antineoplastic (glioma)
0,598  0,007  Antimitotic
0,596  0,013  Chemopreventive
0,576  0,004  Acetylcholinesterase inhibitor
0,596  0,026  TNF expression inhibitor
0,574  0,007  Antineoplastic enhancer
0,573  0,011  GABA C receptor rho-3 antagonist
0,587  0,033  Transcription factor NF kappa B inhibitor
0,561  0,007  Antineoplastic (carcinoma)
0,571  0,017  Aryl hydrocarbon receptor agonist
0,568  0,019  Antineoplastic (ovarian cancer)
0,553  0,005  Antineoplastic (squamous cell carcinoma)
0,551  0,004  NADPH oxidase inhibitor
0,558  0,013  Ulceration
0,551  0,014  Antineoplastic (brain cancer)
0,544  0,009  Antineoplastic (glioblastoma multiforme)
0,546  0,015  CYP2C19 inhibitor
0,532  0,007  Peroxidase inhibitor
0,524  0,006  UGT1A3 substrate
0,527  0,011  UGT1A6 substrate
0,537  0,023  Antipruritic, allergic
0,525  0,018  Cytostatic
0,506  0,005  Cholinergic
0,518  0,018  Proliferative diseases treatment
0,503  0,004  UGT2B15 substrate
0,504  0,007  MAO inhibitor
0,505  0,013  DNA damaging
0,493  0,005  MAO A inhibitor
0,495  0,009  Antineoplastic (sarcoma)
0,490  0,005  Antineoplastic (gastric cancer)
0,499  0,023  Spasmolytic
0,489  0,015  Tumour necrosis factor alpha release inhibitor
0,485  0,011  UGT1A1 substrate
0,494  0,019  Lipoxygenase inhibitor
0,475  0,005  5 Hydroxytryptamine uptake stimulant
0,471  0,004  Cystathionine beta-synthase inhibitor
0,464  0,013  Antineoplastic (liver cancer)
0,521  0,075  Alpha-glucosidase inhibitor
0,486  0,043  15-Lipoxygenase inhibitor
0,441  0,004  Electron transport complex I inhibitor
0,441  0,006  Pneumotoxic
0,450  0,016  Vasodilator
0,452  0,023  ICAM1 expression inhibitor
0,456  0,027  Antineoplastic (pancreatic cancer)
0,447  0,020  Nitric oxide antagonist
0,442  0,023  Antiamyloidogenic
0,440  0,022  UGT2B4 substrate
0,444  0,029  NOS3 expression inhibitor
0,444  0,032  CYP1A2 substrate
0,443  0,037  5 Hydroxytryptamine release stimulant
0,425  0,019  Antihypoxic
0,410  0,004  Xanthine oxidase inhibitor
0,415  0,011  Melanin inhibitor
0,406  0,006  Butyrylcholinesterase inhibitor
0,432  0,032  Radioprotector
0,437  0,043  CYP2C9 inhibitor
0,406  0,012  Skin whitener
0,414  0,023  Cardiodepressant
0,388  0,003  Multidrug resistance-associated protein 1 inhibitor
0,434  0,052  CYP2C9 substrate
0,388  0,006  CYP2B6 inhibitor
0,404  0,023  Antineoplastic (renal cancer)
0,388  0,009  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,414  0,034  Apoptosis antagonist
0,382  0,004  Carbonic anhydrase XIII inhibitor
0,385  0,009  Protein kinase stimulant
0,397  0,021  UDP-glucuronosyltransferase substrate
0,388  0,014  Antiseptic
0,388  0,014  Hepatoprotectant
0,430  0,057  Antiprotozoal
0,399  0,030  Hypoxia-inducible factor 1 alpha inhibitor
0,384  0,015  GST M1-1 substrate
0,376  0,008  Tumour necrosis factor antagonist
0,387  0,022  Antineoplastic (small cell lung cancer)
0,402  0,044  Antihypercholesterolemic
0,357  0,004  Alpha tubulin antagonist
0,384  0,032  Cardiovascular analeptic
0,396  0,046  FMO1 substrate
0,353  0,006  Antihemorrhagic
0,350  0,004  Beta tubulin antagonist
0,348  0,004  GABA C receptor rho-2 antagonist
0,364  0,021  Antineoplastic (bladder cancer)
0,352  0,009  MAO B inhibitor
0,354  0,014  Monophenol monooxygenase inhibitor
0,367  0,028  Pyruvate kinase inhibitor
0,360  0,023  RNA-directed DNA polymerase inhibitor
0,349  0,013  Topoisomerase II inhibitor
0,446  0,112  Antiinflammatory
0,398  0,067  Prostaglandin dehydrogenase inhibitor
0,365  0,036  Antiprotozoal (Trypanosoma)
0,331  0,004  Antineoplastic (uterine cancer)
0,355  0,032  Vascular (periferal) disease treatment
0,397  0,083  Calcium channel L-type activator
0,315  0,004  Antihelmintic (Trematoda)
0,316  0,006  Topoisomerase II alpha inhibitor
0,325  0,015  Amylase inhibitor
0,318  0,008  Nitric-oxide synthase stimulant
0,348  0,039  Antineoplastic (osteosarcoma)
0,310  0,005  Telomerase inhibitor
0,327  0,023  Antihypotensive
0,319  0,015  Genotoxic
0,308  0,004  Aldose reductase inhibitor
0,363  0,062  Antiallergic
0,302  0,004  Histone deacetylase SIRT1 stimulant
0,302  0,004  Histone deacetylase stimulant
0,341  0,045  Antineoplastic (multiple myeloma)
0,343  0,055  Calcium channel activator
0,317  0,029  Platelet adhesion inhibitor
0,311  0,026  Non-steroidal antiinflammatory agent
0,329  0,043  Antineoplastic (lymphoma)
0,289  0,005  NAD(P)H dehydrogenase (quinone) inhibitor
0,294  0,013  Alkaline phosphatase inhibitor
0,289  0,009  Interleukin 4 antagonist
0,305  0,028  Dual specificity phosphatase inhibitor
0,281  0,005  Gastritis treatment
0,335  0,058  CYP3A4 inhibitor
0,349  0,073  Antiprotozoal (Plasmodium)
0,282  0,006  VEGF expression inhibitor
0,353  0,077  CYP3A4 substrate
0,287  0,012  Carcinogenic, group 1
0,330  0,056  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,322  0,049  Antipyretic
0,298  0,027  DNA methyltransferase I inhibitor
0,282  0,010  Gout treatment
0,317  0,047  Hypoglycemic
0,289  0,020  Lipid peroxidase inhibitor
0,273  0,006  Calcium antagonist
0,301  0,038  Antihypertriglyceridemic
0,266  0,005  Creatine kinase inhibitor
0,291  0,030  Dual specificity phosphatase 3 inhibitor
0,287  0,029  UGT2B7 substrate
0,308  0,052  Radiosensitizer
0,316  0,060  CYP2C19 substrate
0,284  0,031  VCAM1 expression inhibitor
0,294  0,045  Antineoplastic (lymphocytic leukemia)
0,266  0,017  Succinate dehydrogenase inhibitor
0,255  0,007  Phosphodiesterase IV inhibitor
0,318  0,073  Hepatic disorders treatment
0,259  0,014  5-Lipoxygenase inhibitor
0,299  0,056  Transcription factor STAT inhibitor
0,269  0,026  Amyloid beta precursor protein antagonist
0,313  0,070  Respiratory analeptic
0,259  0,017  LDLR expression enhancer
0,298  0,056  Sensitization
0,259  0,018  Antineoplastic (bone cancer)
0,254  0,015  SULT1A3 substrate
0,251  0,012  Carbonic anhydrase XV inhibitor
0,289  0,053  Cytotoxic
0,309  0,077  CYP2D6 substrate
0,240  0,009  Beta glucuronidase inhibitor
0,235  0,008  Phosphodiesterase 4D inhibitor
0,250  0,025  Bone formation stimulant
0,264  0,041  DNA methylase inhibitor
0,260  0,038  UGT1A4 substrate
0,237  0,016  Phobic disorders treatment
0,238  0,020  Antiprotozoal (Coccidial)
0,222  0,004  DNA-dependent protein kinase inhibitor
0,240  0,023  UGT2B9 substrate
0,224  0,013  Carbonic anhydrase III inhibitor
0,348  0,140  DNA polymerase beta inhibitor
0,226  0,021  UGT2B10 substrate
0,218  0,015  SULT1A1 substrate
0,210  0,012  Carbonic anhydrase VI inhibitor
0,227  0,032  Cyclooxygenase inhibitor
0,198  0,004  Protease activated receptor antagonist
0,286  0,095  Thyroid hormone beta antagonist
0,270  0,079  Insulysin inhibitor
0,195  0,004  Xanthine dehydrogenase inhibitor
0,288  0,099  Thyroid hormone antagonist
0,249  0,064  Cyclic AMP phosphodiesterase inhibitor
0,260  0,076  Transcription factor STAT3 inhibitor
0,212  0,028  Cyclooxygenase 2 inhibitor
0,241  0,057  Carcinogenic
0,209  0,026  Aldehyde dehydrogenase inhibitor
0,239  0,057  Mutagenic
0,191  0,009  GABA C receptor rho-1 antagonist
0,230  0,049  I kappa B kinase epsilon inhibitor
0,188  0,009  Heat shock protein 70 antagonist
0,191  0,012  Protein kinase C zeta inhibitor
0,183  0,005  Thioredoxin reductase inhibitor
0,229  0,052  Neurotrophic factor enhancer
0,206  0,032  M18 aspartyl aminopeptidase inhibitor
0,268  0,095  Analeptic
0,216  0,043  3C-like protease (Human coronavirus) inhibitor
0,277  0,105  Antithrombotic
0,206  0,034  Cytokine production inhibitor
0,191  0,022  Cyclooxygenase 3 inhibitor
0,182  0,013  Urease inhibitor
0,224  0,056  Antihelmintic
0,217  0,050  Antipruritic, non-allergic
0,269  0,102  Bone diseases treatment
0,233  0,069  Antiparasitic
0,236  0,073  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,202  0,040  NOS3 expression enhancer
0,183  0,023  Beta amyloid protein antagonist
0,178  0,018  Photosensitizer
0,204  0,045  Protein-tyrosine phosphatase inhibitor
0,188  0,029  Topoisomerase I inhibitor
0,278  0,123  GST A substrate
0,317  0,163  MAP kinase 1 inhibitor
0,170  0,017  DNA repair enzyme inhibitor
0,191  0,038  Cyclooxygenase 1 inhibitor
0,164  0,011  Aromatase inhibitor
0,164  0,012  Macrophage migration inhibitory factor inhibitor
0,171  0,020  Papain-like protease (SARS coronavirus) inhibitor
0,208  0,058  Histone acetyltransferase inhibitor
0,193  0,043  Interferon gamma antagonist
0,155  0,006  Carbonic anhydrase VII inhibitor
0,215  0,067  Anesthetic general
0,222  0,075  Antiviral (West Nile virus)
0,158  0,015  Antifungal (Pneumocystis)
0,188  0,045  Arachidonic acid antagonist
0,165  0,023  Sulfotransferase substrate
0,165  0,024  Contraceptive female
0,198  0,057  Muscle relaxant
0,155  0,015  CYP2A6 inhibitor
0,175  0,036  Toll-Like receptor 2 antagonist
0,170  0,032  Protein kinase (CK2) alpha inhibitor
0,180  0,042  Mannose-6-phosphate isomerase inhibitor
0,157  0,023  Dementia treatment
0,297  0,163  DNA directed DNA polymerase inhibitor
0,159  0,025  Mediator release inhibitor
0,138  0,005  Potassium channel Kv1.3 blocker
0,227  0,094  Tyrosine 3 hydroxylase inhibitor
0,282  0,149  Antibacterial
0,163  0,031  Coagulant
0,140  0,008  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,233  0,102  Antiosteoporotic
0,169  0,038  Protein-tyrosine phosphatase 1B inhibitor
0,151  0,023  Vascular dementia treatment
0,167  0,039  Alkylator
0,215  0,090  Dyrk kinase inhibitor
0,175  0,052  Insulin secretagoues
0,196  0,075  Abortion inducer
0,144  0,024  Carcinogenic, group 2A
0,126  0,007  Aryl hydrocarbon receptor antagonist
0,123  0,004  GABA B receptor antagonist
0,292  0,174  Alzheimer's disease treatment
0,135  0,017  Cyclin B3 inhibitor
0,138  0,021  Thioredoxin inhibitor
0,247  0,130  Vasodilator, peripheral
0,147  0,032  GABA C receptor antagonist
0,141  0,026  Uric acid excretion stimulant
0,119  0,005  Glutamate (mGluR7) antagonist
0,115  0,004  Transcription factor RelA inhibitor
0,126  0,017  Myeloperoxidase inhibitor
0,163  0,054  Hemostatic
0,178  0,070  Antirickettsial
0,121  0,013  D-Ala-D-Ala ligase inhibitor
0,138  0,030  Sphingomyelinase inhibitor
0,188  0,083  Antiviral (Ebola)
0,124  0,018  HIV-1 integrase (3'-Processing) inhibitor
0,161  0,057  Skeletal muscle relaxant
0,199  0,095  Angiogenesis stimulant
0,216  0,113  5 Hydroxytryptamine 1E antagonist
0,135  0,033  Estrogen antagonist
0,137  0,035  UGT2B1 substrate
0,126  0,026  Estrogen receptor beta antagonist
0,132  0,033  DOPA decarboxylase inhibitor
0,196  0,096  Teratogen
0,161  0,063  Heat shock protein 90 antagonist
0,145  0,048  Antitussive
0,117  0,020  CDC25A inhibitor
0,115  0,019  Granulocyte macrophage colony stimulating factor agonist
0,125  0,030  UGT2B11 substrate
0,139  0,046  Antiviral (Papilloma)
0,097  0,007  Postcoital contraceptive
0,136  0,046  Glutathione S-transferase substrate
0,130  0,041  AMP-activated protein kinase stimulant
0,142  0,054  Antibacterial (Helicobacter pylori)
0,130  0,044  Expectorant
0,219  0,133  Antifungal
0,125  0,040  Acetylcholine release stimulant
0,105  0,021  HIV-1 integrase (Strand Transfer) inhibitor
0,149  0,065  Adenylate cyclase stimulant
0,145  0,063  Antifungal enhancer
0,158  0,077  Interleukin 6 antagonist
0,219  0,138  FMO3 substrate
0,112  0,032  Ornithine decarboxylase inhibitor
0,086  0,006  Ryanodine receptor antagonist
0,127  0,048  Mucolytic
0,176  0,098  MAP kinase kinase 2 inhibitor
0,121  0,044  Bronchodilator
0,103  0,025  Estrogen receptor alpha antagonist
0,176  0,100  Insulin sensitizer
0,087  0,012  Topoisomerase II beta inhibitor
0,103  0,030  Histidine decarboxylase inhibitor
0,098  0,026  Carbonic anhydrase VA inhibitor
0,148  0,075  Antiviral (Influenza A)
0,177  0,106  Antiulcerative
0,140  0,069  Toll-Like receptor 9 antagonist
0,133  0,063  Carcinogenic, group 3
0,117  0,050  Protein kinase (CK2) inhibitor
0,100  0,033  mTOR complex 2 inhibitor
0,120  0,053  Choleretic
0,095  0,029  Carbonic anhydrase V inhibitor
0,157  0,090  ATPase inhibitor
0,171  0,105  Platelet aggregation inhibitor
0,096  0,033  Keratolytic
0,097  0,034  Phosphodiesterase 3A inhibitor
0,067  0,005  Nucleoside transporters inhibitor
0,083  0,021  Postmenopausal disorders treatment
0,110  0,049  GST P1-1 substrate
0,132  0,071  Phosphodiesterase inhibitor
0,214  0,154  Angiogenesis inhibitor
0,078  0,020  Fatty acid synthase inhibitor
0,166  0,108  Embryotoxic
0,122  0,063  Antiviral (Influenza B)
0,140  0,082  Antidote
0,073  0,015  Estradiol 17 beta-dehydrogenase inhibitor
0,091  0,033  Lipase inhibitor
0,182  0,125  Antidiabetic symptomatic
0,111  0,054  Toll-Like receptor 4 antagonist
0,107  0,052  Alpha adrenoreceptor antagonist
0,070  0,016  Glucose-6-phosphate translocase inhibitor
0,069  0,015  CD45 antagonist
0,111  0,058  Antiviral (Coronavirus)
0,111  0,058  Antiviral (SARS coronavirus)
0,072  0,019  Carbonic anhydrase XIV inhibitor
0,099  0,046  Antidote, mercury
0,101  0,049  Antiviral (Rhinovirus)
0,116  0,065  Microtubule formation inhibitor
0,124  0,074  Retinoprotector
0,081  0,031  Leukotriene antagonist
0,095  0,047  Antiviral (Hepatitis A)
0,111  0,063  Chelator
0,116  0,069  Cholesterol synthesis inhibitor
0,149  0,102  Aldehyde oxidase substrate
0,149  0,103  Neurotensin receptor agonist
0,058  0,013  Dopamine D5 agonist
0,092  0,047  Alpha 1 adrenoreceptor antagonist
0,094  0,049  Interleukin 5 antagonist
0,135  0,093  Ca2+-transporting ATPase inhibitor
0,126  0,085  Neurotrophic factor
0,141  0,099  Mcl-1 antagonist
0,096  0,056  Alcohol dehydrogenase inhibitor
0,174  0,135  Myocardial infarction treatment
0,128  0,088  Acaricide
0,070  0,033  Beta 3 adrenoreceptor antagonist
0,170  0,133  ErbB-1 antagonist
0,101  0,065  Alpha 2c adrenoreceptor antagonist
0,047  0,011  Vanilloid 3 antagonist
0,157  0,123  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,111  0,077  Transcription factor STAT6 inhibitor
0,091  0,057  Phosphodiesterase I inhibitor
0,042  0,008  Estrone sulfatase inhibitor
0,187  0,153  Flavin-containing monooxygenase substrate
0,103  0,069  GST T1-1 substrate
0,067  0,034  Calcium channel P-type blocker
0,136  0,104  CF transmembrane conductance regulator agonist
0,116  0,084  Antihyperlipoproteinemic
0,120  0,087  Antiprotozoal (Trichomonas)
0,102  0,070  Antiprotozoal (Toxoplasma)
0,076  0,045  Phosphodiesterase V inhibitor
0,148  0,117  Antiviral (Influenza)
0,148  0,118  Antiviral (Hepatitis)
0,039  0,010  Dopamine autoreceptor agonist
0,148  0,118  Psychostimulant
0,148  0,118  Toxic, respiratory center
0,169  0,140  5 Hydroxytryptamine 3E antagonist
0,084  0,055  Antineoplastic antibiotic
0,101  0,073  Antifungal (Aspergillus)
0,070  0,044  Exportin-1 inhibitor
0,058  0,033  Carbonic anhydrase XII inhibitor
0,072  0,048  Phosphodiesterase 5A inhibitor
0,056  0,032  Estrogen agonist
0,063  0,040  Phosphodiesterase 1C inhibitor
0,082  0,059  Inducible nitric-oxide synthase inhibitor
0,118  0,096  Antiparkinsonian, tremor relieving
0,188  0,167  Gastrin inhibitor
0,074  0,053  Phosphodiesterase VI inhibitor
0,102  0,082  Nav1.5 sodium channel blocker
0,137  0,117  Sedative
0,056  0,037  Protein kinase C eta inhibitor
0,049  0,029  Benzodiazepine antagonist
0,111  0,092  Contraceptive
0,038  0,020  ATM kinase inhibitor
0,254  0,236  Antineoplastic (solid tumors)
0,052  0,034  Anesthetic inhalation
0,051  0,034  Sigma receptor antagonist
0,141  0,125  Antiarrhythmic
0,065  0,049  Leukotriene synthesis inhibitor
0,056  0,040  Leukotriene C antagonist
0,054  0,039  GABA receptor antagonist
0,222  0,207  Transcription factor inhibitor
0,055  0,040  Carbonic anhydrase VB inhibitor
0,103  0,089  Antiprotozoal (Babesia)
0,071  0,057  Adenosine A3 receptor antagonist
0,078  0,065  Caspase 7 inhibitor
0,079  0,066  Androgen antagonist
0,033  0,021  Estrogen-related receptor beta antagonist
0,128  0,115  Male reproductive disfunction treatment
0,082  0,070  NADH dehydrogenase inhibitor
0,200  0,188  Sodium/bile acid cotransporter inhibitor
0,182  0,170  Antimycobacterial
0,058  0,046  Cyclin D1 inhibitor
0,035  0,026  Inosine monophosphate dehydrogenase inhibitor
0,129  0,119  Muscular dystrophy treatment
0,032  0,023  Sirtuin 2 inhibitor
0,087  0,079  Cyclin-dependent kinase 9 inhibitor
0,043  0,036  Neuraminidase (Influenza A) inhibitor
0,075  0,068  Antidote, organophosphates
0,058  0,052  Dopamine D1 antagonist
0,030  0,025  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,090  0,085  Glutamate (mGluR7) agonist
0,167  0,162  Antituberculosic
0,064  0,061  SULT2A1 substrate
0,049  0,046  Leukotriene B4 antagonist
0,020  0,018  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,082  0,080  SULT1E1 substrate
0,183  0,181  Cholesterol antagonist
0,011  0,010  Melatonin 2 antagonist
0,045  0,043  Dopamine D4 agonist
0,075  0,074  Alpha 2 adrenoreceptor antagonist
0,057  0,056  CDC25B inhibitor

